Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112812032B reveals a green Rh-catalyzed route using DMC. Offers cost-effective, scalable production of high-purity acetamide intermediates.
Patent CN116496215B reveals advanced palladium-catalyzed carbonylation for high-purity pharmaceutical intermediates with streamlined supply chain advantages.
Novel acid-catalyzed cyclization for fused biindoles. Mild conditions, high purity, scalable process for pharmaceutical intermediates and drug discovery.
Patent CN116640146A reveals a novel Pd-catalyzed one-pot synthesis for trifluoromethyl chromonoquinolines, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN110467579B reveals a novel iodine-promoted synthesis route offering significant cost reduction and scalable manufacturing for high-purity pharmaceutical intermediates.
Patent CN107382899B reveals a mild, one-pot synthesis for 2-hydroxy-1,4-benzoxazine derivatives, offering high yields and simplified supply chains for API manufacturing.
Patent CN114456089B details a novel cobalt-catalyzed three-component reaction enabling efficient synthesis of amino-nitrile pharmaceutical intermediates with reduced costs.
Patent CN113105402B reveals a metal-free iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN118619879A reveals a novel Rhodium-catalyzed C-H activation route for trifluoromethyl enaminones, offering scalable supply chain solutions and cost efficiency.
Novel AlCl3-catalyzed route offers high stereoselectivity and mild conditions for scalable production of key pharmaceutical intermediates.
Patent CN105646382A reveals iodine-catalyzed synthesis offering cost reduction and scalable supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN113880781B reveals glucose-based synthesis for triazoles offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing processes globally.
Novel cobalt-catalyzed C-H carbonylation for indolo[1,2-a]quinazolin-6(5H)-ones. Cost-effective, scalable route for pharmaceutical intermediates.
Novel radical amino migration patent enables mild benzolactam synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN112239436A details a novel Pd-catalyzed bis-carbonylation route for 4-acyl-2(5H)-furanones, offering high yields and simplified operations for API manufacturing.
Patent CN111978237A details a novel Cu-catalyzed four-component coupling for high-purity maleimide intermediates, offering significant cost reduction and supply chain reliability.
Novel DES-mediated synthesis of benzoxazine derivatives offers green, high-yield routes for pharmaceutical intermediates, reducing costs and environmental impact.
Novel carbonylation method using sulfonyl chlorides avoids toxic thiols. High purity thioesters for pharma intermediates with simplified supply chain.
Novel defluorination coupling method enables cost reduction in pharmaceutical intermediate manufacturing with high substrate adaptability and scalable production capabilities for global supply chains.
Novel Mo/Cu co-catalyzed method for high-purity triazole intermediates. Reduces steps and costs for API manufacturing with mild conditions.